Transporter (TAP)-independent processing of a multiple membrane-spanning protein, the Epstein-Barr virus latent membrane protein 2. (Q41180520)

27 September 2017

Transporter (TAP)-independent processing of a multiple membrane-spanning protein, the Epstein-Barr virus latent membrane protein 2. (English)

1 reference

27 September 2017

0 references

1 reference

Lee SP

1

1 reference

27 September 2017

Thomas WA

series ordinal

2

1 reference

27 September 2017

Blake NW

series ordinal

3

1 reference

27 September 2017

Rickinson AB

series ordinal

4

1 reference

27 September 2017

language of work or name

English

0 references

publication date

1 August 1996

1 reference

European Journal of Immunology

27 September 2017

1 reference

27 September 2017

26

1 reference

27 September 2017

8

1 reference

27 September 2017

1875-1883

1 reference

MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation

27 September 2017

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260831

7 January 2021

Generation, translocation, and presentation of MHC class I-restricted peptides

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260831

7 January 2021

Selective and ATP-dependent translocation of peptides by the MHC-encoded transporter

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260831

7 January 2021

TAP1-dependent peptide translocation in vitro is ATP dependent and peptide selective

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260831

7 January 2021

Cellular peptide composition governed by major histocompatibility complex class I molecules.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260831

7 January 2021

Presentation of viral antigen controlled by a gene in the major histocompatibility complex

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260831

7 January 2021

Proteasome subunits encoded in the MHC are not generally required for the processing of peptides bound by MHC class I molecules

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260831

7 January 2021

Proteasome subunits encoded by the major histocompatibility complex are not essential for antigen presentation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260831

7 January 2021

Genes encoded in the major histocompatibility complex affecting the generation of peptides for TAP transport

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260831

7 January 2021

Transporter-independent processing of HIV-1 envelope protein for recognition by CD8+ T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260831

7 January 2021

Measles virus transmembrane fusion protein synthesized de novo or presented in immunostimulating complexes is endogenously processed for HLA class I- and class II-restricted cytotoxic T cell recognition

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260831

7 January 2021

Processing of major histocompatibility class I-restricted antigens in the endoplasmic reticulum

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260831

7 January 2021

HLA-A2 molecules in an antigen-processing mutant cell contain signal sequence-derived peptides

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260831

7 January 2021

HLA-A2.1-associated peptides from a mutant cell line: a second pathway of antigen presentation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260831

7 January 2021

T cell recognition of an HLA-A2-restricted epitope derived from a cleaved signal sequence

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260831

7 January 2021

Endogenously synthesized peptide with an endoplasmic reticulum signal sequence sensitizes antigen processing mutant cells to class I-restricted cell-mediated lysis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260831

7 January 2021

Expression of a membrane protease enhances presentation of endogenous antigens to MHC class I-restricted T lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260831

7 January 2021

Genes regulating HLA class I antigen expression in T-B lymphoblast hybrids.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260831

7 January 2021

Homozygous deletions that simultaneously eliminate expressions of class I and class II antigens of EBV-transformed B-lymphoblastoid cells. I. Reduced proliferative responses of autologous and allogeneic T cells to mutant cells that have decreased ex

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260831

7 January 2021

Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260831

7 January 2021

Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260831

7 January 2021

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260831

7 January 2021

A second Epstein-Barr virus membrane protein (LMP2) is expressed in latent infection and colocalizes with LMP1.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260831

7 January 2021

HLA-A11 epitope loss isolates of Epstein-Barr virus from a highly A11+ population

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260831

7 January 2021

Endemic Burkitt's lymphoma: phenotypic analysis of tumor biopsy cells and of derived tumor cell lines

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260831

7 January 2021

Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260831

7 January 2021

Different HLA-B27 subtypes present the same immunodominant Epstein-Barr virus peptide

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260831

7 January 2021

Multiple HLA class I-dependent cytotoxicities constitute the "non-HLA-restricted" response in infectious mononucleosis.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260831

7 January 2021

MHC class II-restricted presentation of endogenously synthesized antigen: Epstein-Barr virus transformed B cell lines can present the viral glycoprotein gp340 by two distinct pathways

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260831

7 January 2021

Class I major histocompatibility complex-restricted cytotoxic T lymphocytes specific for Epstein-Barr virus (EBV)-transformed B lymphoblastoid cell lines against which they were raised

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260831

7 January 2021

TAP1-independent loading of class I molecules by exogenous viral proteins

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260831

7 January 2021

Brefeldin A implicates egress from endoplasmic reticulum in class I restricted antigen presentation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260831

7 January 2021

Brefeldin A specifically inhibits presentation of protein antigens to cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260831

7 January 2021

Differences in antigen presentation to MHC class I-and class II-restricted influenza virus-specific cytolytic T lymphocyte clones

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260831

7 January 2021

Endoplasmic reticulum signal sequence facilitated transport of peptide epitopes restores immunogenicity of an antigen processing defective tumour cell line.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260831

7 January 2021

A new foreign policy: MHC class I molecules monitor the outside world

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260831

7 January 2021

Presentation of an exogenous antigen by major histocompatibility complex class I molecules.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260831

7 January 2021

Antigen processing mutant T2 cells present viral antigen restricted through H-2Kb

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260831

7 January 2021

Hepatitis B virus small surface antigen particles are processed in a novel endosomal pathway for major histocompatibility complex class I-restricted epitope presentation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260831

7 January 2021

An Epstein-Barr virus transformation-associated membrane protein interacts with src family tyrosine kinases

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260831

7 January 2021

Transport of proteins across the endoplasmic reticulum membrane

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260831

7 January 2021

The protein-conducting channel in the membrane of the endoplasmic reticulum is open laterally toward the lipid bilayer.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260831

7 January 2021

Degradation of CFTR by the ubiquitin-proteasome pathway

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260831

7 January 2021

Multiple proteolytic systems, including the proteasome, contribute to CFTR processing.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260831

7 January 2021

Degradation of subunits of the Sec61p complex, an integral component of the ER membrane, by the ubiquitin-proteasome pathway.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260831

7 January 2021

Identifiers

DOI

10.1002/EJI.1830260831

1 reference

27 September 2017

1 reference